Are Compounded GLP-1s Safe and Effective?

“Not FDA-approved, these receptor agonists are prepared by licensed compounding pharmacies or outsourcing facilities.”

Compounded GLP-1 medications are generally custom-made by specialty pharmacies to meet a specific patient's needs, such as replacing an ingredient when the patient has an allergy to an inactive ingredient. Unlike brand-name drugs, compounded GLP-1 medications for semaglutide and tirzepatide have not been evaluated or approved by the FDA for safety, effectiveness, or quality. While they contain similar active ingredients, they may carry a higher risk of dosing errors, variable potency, and contamination.

For roughly two years, the FDA permitted both 503A compounding pharmacies (state-licensed facilities that prepare customized medications for individual patients) and 503B outsourcing facilities (bulk producers subject to stricter FDA oversight) to compound semaglutide and tirzepatide under drug shortage exceptions. That changed in spring 2025, when both medications were removed from the drug shortage list, which effectively ended the legitimate use of most compounded versions without patient-specific reasons documented by a doctor.

Since then, illicit sources of compounded GLP-1s have surged. As of July 31, 2025, the FDA has received 605 adverse event reports linked to compounded semaglutide and 545 linked to compounded tirzepatide. Some online providers claim to offer popular GLP-1s at lower prices and different formulations, especially for oral tabs, gel patches, or chiclet-style gums. But, the FDA has explicitly warned against purchasing online medications outside of state-licensed pharmacies. In April 2025, banned the sale of counterfeit versions entirely.

So, what are the core problems? Many of the counterfeit online products may contain the wrong ingredients with incorrect dosing of active ingredients, or no active ingredients at all (which is a dietary supplement). In addition to potency of compounded versions, glucagon-like peptide-1 medications can vary from one batch to another, which makes product outcomes unpredictable. Non-injectable formats like sublingual drops or oral sprays have no clinical evidence supporting their absorption or effectiveness.

NOTE: As always, patients should speak with their doctor to weigh the risks and benefits of using a prescription compounded version of a medication based on their individual circumstances and needs. The Obesity Medicine Association also published a position statement on the use of GLP-1 medications for chronic weight management.

What are safety concerns about compounded medications?

While compounded GLP-1 prescription medications use similar (but not the same) active ingredients, they carry higher risks of dosing errors, variable potency, and contamination compared to brand-name formulations of semaglutide or tirzepatide. Here are reasons the FDA suggests you may want to discuss alternative medical options with you’re a professional healthcare provider:

• No FDA Oversight: Compounded drugs do not go through the rigorous clinical trials required for FDA approval of traditional medications that are commercially manufactured.
• Unverified Ingredients: Some pharmacies use alternate salt forms (like semaglutide sodium) that lack clinical proof of safety and overall effectiveness.
• Inconsistent Strength: Without strict manufacturing standardization, different batches may contain more or less of the active medication than stated on the label.
• Stability and Purity: Peptides are fragile critters and improper mixing, handling, or temperature control during shipping can degrade the drug or introduce impurities.
• Dosing Mistakes: Unlike brand-name single-use pens, compounded versions often come in multi-dose vials requiring manual syringe measurement, leading to accidental overdoses.
• Unproven Alternative Formulations: Non-injection forms (such as sublingual drops, chewing gum, or patches) lack clinical data showing they work the same way as approved injections.

Brand name glucagon-like peptide-1 receptor agonists are FDA-approved, mass-produced brand-name drugs with rigorous safety and precise dosing. Compounded GLP-1s, on the other hand, are custom-mixed alternatives made by specialized licensed compounding pharmacies. They are not FDA-approved and lack large-scale clinical trial verification. They also carry higher risks of dosing errors or ingredient purity, though they allow your doctor to prescribe a more personalized delivery of the medication.

Can a compounded semaglutide be better than non-compounded?

Compounding means a pharmacy customizes the medication to suit your specific needs. While it offers similar benefits, it's not FDA-approved, so quality and effectiveness can vary depending on which pharmacy is compounding it. Unlike FDA-approved GLP-1ra, which are available in standard concentrations and prefilled pens, compounded versions may come in multiple-dose vials or prefilled syringes with varying strengths. On the other hand, compounded semaglutide may be a more affordable alternative to the standard prescription version, but the lack of pharmaceutical standardization as a manufacturer does increase the risk of miscalculation or unintentionally drawing up an inappropriate dose. Without clinical trial testing, some doctors hesitate to use compounding pharmacies due to unknown drug effectiveness and patient safety risks.

_______________________

Compounded medications are not evaluated by the U.S. Food and Drug Administration for safety, effectiveness, or quality. This means both patient risks and patient benefits taking prescriptive compounded GLP-1s cannot be guaranteed through FDA-approval. While they may share active ingredients with brand-name drugs, they bypass standard clinical trials and manufacturing oversight. Frequently supplied in multi-dose vials that require manual measurement with syringes does increase the risk of accidental overdosing. Moreover, non-injectable counterfeit formulations, such as sublingual drops, oral sprays, or chewing gum lack the clinical proof that they are absorbed effectively in humans. At Metabolic Research Center Valdosta, our goal is to provide the GLP-1 support needed to create a customized program that preserves crucial muscle mass, limits the common side effects of using a GLP-1 receptor agonist, and produces the changes your body needs for sustainable weight control.